1. A patient has been treated with a number of novel psychotropic drugs. How is it theoretically possible to identify cognitive improvement in the patient using neuropsychological assessment batteries after the pharmacologic therapy? I did not have this question
A.
Obtaining raw normative metrics and using them to assess functionality
B.
Having the patient report on cognitive function based on personal experiences
C.
Monitoring the patient in a controlled setting
D.
Measuring symptoms of psychosis